← Back to headlines
AbCellera Stock Soars 64% on Drug Candidate's Market Opportunity
AbCellera (ABCL) shares surged by 64% following news that a drug candidate developed by the company holds a significant market opportunity, attracting investor interest.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
